Protara Therapeutics GAAP EPS of -$0.31 beats by $0.07

* Protara Therapeutics press release [https://seekingalpha.com/pr/20300363-protara-therapeutics-announces-third-quarter-2025-financial-results-and-provides-business] (TARA [https://seekingalpha.com/symbol/TARA]): Q3 GAAP EPS of -$0.31 beats by $0.07.
* Cash, cash equivalents and investments of approximately $134 million as of September 30, 2025, expected to support planned operations into mid-2027

MORE ON PROTARA THERAPEUTICS

* Seeking Alpha’s Quant Rating on Protara Therapeutics [https://seekingalpha.com/symbol/TARA/ratings/quant-ratings]
* Historical earnings data for Protara Therapeutics [https://seekingalpha.com/symbol/TARA/earnings]
* Financial information for Protara Therapeutics [https://seekingalpha.com/symbol/TARA/income-statement]